Teva Reports Second Quarter 2013 Results

mia.burns Net Revenues of $ 4.9 Billion Non-GAAP Diluted EPS of $ 1.20, GAAP Diluted EPS Loss of $ 0.53 JERUSALEM–(BUSINESS WIRE)–Aug. 1, 2013– Teva Pharmaceutical ...

Cigna Reports Strong Second Quarter 2013 Results, Raises Outlook

barbara.lempert •    Consolidated revenues increased 8% to $ 8.0 billion in the second quarter. •    Adjusted income from operations1 was $ 512 million, or $ 1.78 per ...

Seattle Genetics Reports Second Quarter 2013 Financial Results

barbara.lempert -Total Revenues of $ 73.6 Million, Including $ 35.7 Million in ADCETRIS® (Brentuximab Vedotin) Net Product Sales- -Company Executing on Broad ADCETRIS Clinical ...

Pharmacyclics Reports Second Quarter 2013 Results

barbara.lempert SUNNYVALE, Calif., July 31, 2013 /PRNewswire/ — Pharmacyclics, Inc. (the “Company”) (Nasdaq: PCYC) today reported financial results and recent developments ...

GAO Report: Private Health Insurance: The Range of Base Premiums in the Individual Market by State in January 2013

barbara.lempert What GAO Found GAO reported the range of base premiums prior to underwriting for health insurance in the individual market that were displayed on the HealthCare.gov ...

InterMune Reports Second Quarter 2013 Financial Results And Business Highlights

barbara.lempert — Reports 7th Consecutive Quarter of Esbriet Revenue Growth–   BRISBANE, Calif., July 24, 2013 /PRNewswire/ — InterMune, Inc. (NASDAQ: ITMN) today ...

WILEX publishes half-yearly financial report 2013

barbara.lempert WILEX publishes half-yearly financial report 2013 • Positive subgroup data for RENCAREX® presented at the ASCO Annual Meeting • Agreement reached with the FDA ...

To the Point, June 2013

chris.truelove I had an urge to restart my garden this year. Spare moments were spent clearing out my two raised beds, hacking up turf, moving many cubic feet of dirt, installing three ...

Pharma market in Poland set to rebound in 2013

mia.burns In 2012, the pharmacy market in Poland has recorded negative growth for the first time in many years and fell 6% year on year. These developments were mostly driven by the ...

People on the Move, July 2013

chris.truelove Biopharma • Bryan G. Morton is named non-executive chairman, Oxford BioTherapeutics. Morton was previously CEO of EUSA Pharma. Oxford (oxfordbiotherapeutics.com) is ...

3D Cell Culture Market Trends 2013 Research & Survey Report

barbara.lempert DALLAS, July 17, 2013 /PRNewswire/ — RnRMarketResearch.com adds a 2013 survey report on three dimensional (3D) cell culture technologies that summarizes trends ...

Ad Agency Update – People on the Move, July 2013

chris.truelove • AbelsonTaylorCaitlin K. Fitzgibbons is promoted to senior account executive, AbelsonTaylor (abelsontaylor.com). Ms. Fitzgibbons, formerly an account executive, joined ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS